Stock DYN DYNE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Dyne Therapeutics, Inc.

Equities

DYN

US26818M1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
24.73 USD +4.37% Intraday chart for Dyne Therapeutics, Inc. +3.65% +85.94%
Mar. 25 Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell MT
Mar. 25 Dyne Therapeutics, Inc. Announces Management Changes CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. DYN Stock
  4. Revisions Dyne Therapeutics, Inc.